Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a live attenuated antigenic marker classical swine fever vaccine.

Virology - 5 Feb 2009

Holinka L G, Fernandez-Sainz I, O'Donnell V, Prarat M V, Gladue D P, Lu Z, Risatti G R, Borca M V

Abstract excerpt

Until recently strategies for controlling Classical Swine Fever Virus (CSFV) involve either prophylactic vaccination or non-vaccination with elimination of infected herds depending on the epidemiological situation of the affected geographical area. Marker vaccines allowing distinction between nat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intranasal
Share to Antigens, Viral
Share to Classical Swine Fever

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Classical Swine Fever Virus

Share to Genome, Viral

Share to Injections, Intramuscular

Share to Vaccines, Attenuated

Share to Viral Vaccines

Source

Identifiers

PMID: 19046591
DOI: 10.1016/j.virol.2008.10.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19046591-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a live attenuated antigenic marker classical swine fever vaccine.PMID 19046591Read ↗

Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.Semantic proximity Read ↗

A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine propertiesSemantic proximity Read ↗

Novel marker vaccines against classical swine feverSemantic proximity Read ↗

Development of a classical swine fever subunit marker vaccine and companion diagnostic testSemantic proximity Read ↗

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.Semantic proximity Read ↗

CP7_E2alf: A safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV)Semantic proximity Read ↗

Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.Semantic proximity Read ↗

Deletions of Structural Glycoprotein E2 of Classical Swine Fever Virus Strain Alfort/187 Resolve a Linear Epitope of Monoclonal Antibody WH303 and the Minimal N-Terminal Domain Essential for Binding Immunoglobulin G Antibodies of a Pig Hyperimmune SerumSemantic proximity Read ↗

Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigsSemantic proximity Read ↗

Porvac® subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypesSemantic proximity Read ↗

Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: A reviewSemantic proximity Read ↗

Vaccination against classical swine fever virus: limitations and new strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.